In Brief: GATT legislation
Executive Summary
GATT legislation: Sen. Hatch (R-Utah) pledges to begin hearings in the Judiciary Committee on pharmaceutical patent issues on Feb. 27, 1996 and hold a mark-up by the end of March, according to a Dec. 13 letter to Sen. Pryor (D-Ark.). Pryor's legislation, which would permit generic companies to market products during the extended patent period granted by GATT, was referred to the Judiciary Committee in a 49-48 vote when it was offered as an amendment to the partial-birth abortion ban bill the week of Dec. 8 ("The Pink Sheet" Dec. 11, T&G-7)...